Tag Archives: medical devices

Medical Care Alert Named to University of Florida’s Gator100 List of Fastest Growing Companies for Second Year

NORTHVILLE, Mich. /ScoopCloud/ -- Medical Care Alert, a leading provider of medical alert systems to senior citizens nationwide, has been named to the University of Florida's 2018 Gator100 list of fastest growing alumni companies for the second year in a row. "Being named a Gator100 company two years in a row is a great honor," said Bryan Stapp, President of Medical Care Alert. "With so many of our clients living in Florida, this award holds special significance for us."

Medical Care Alert, the only Michigan-based company to receive the award, was ranked number 68 on the Gator100 list (up from number 88 in 2017) with a three-year compound annual growth rate (CAGR) of 34.27 percent. Results were compiled and certified by Ernst & Young.

"The Gator100 honors UF alumni from across the university who are founding and growing amazing companies around the country," said Kent Fuchs, president of the University of Florida. "It's an incredible affirmation of the innovative and entrepreneurial spirit of the Gator Nation."

Stapp attributed the company's growth to the popularity of its HOME & AWAY line of GPS-enabled mobile medical alert systems. He also noted the company's focus on customer service with an A+ Better Business Bureau (BBB) rating, five consecutive years of Angie's List Super Service Awards, and the Central Station Of The Year award given to Medical Care Alert's monitoring center by industry group CSAA in 2016.

About Medical Care Alert:
Medical Care Alert helps seniors live independently in their own homes with its award-winning "Help At The Press Of A Button" monitoring service. Company offers medical alert systems for every lifestyle, including mobile medical alert systems with GPS, and automatic fall detection technology. Medical alert systems are available with no long term commitment, for around a dollar a day. Medical Care Alert's systems are monitored 24/7 by EMT/EMD-Certified operators based in the United States. Learn more at https://www.medicalcarealert.com/.

Sponsored by the UF Alumni Association, in partnership with the UF Entrepreneurship & Innovation Center, the Gator100 recognizes the 100 fastest-growing businesses owned or led by UF alumni. Ernst & Young calculated each company's compounded annual growth rate (CAGR) over the past three years to generate the ranking.

Learn more about the Gator100 at: https://gator100.ufl.edu/home

@MedicalCareAlrt #Gator100

Medical Care Alert, a leading provider of medical alert systems to senior citizens nationwide, has been named to the University of Florida 2018 Gator100 list of 'fastest growing alumni companies' for the second year in a row. Medical Care Alert, the only Michigan-based company to receive the award, was ranked number 68 on the Gator100 list.

Related link: https://www.medicalcarealert.com/

RoweBots Debuts New Medical and Healthcare RTOS at Medica

DUSSELDORF, Germany /ScoopCloud/ -- Today at Medica, the world's largest medical event, RoweBots, an embedded software company, announces the immediate availability of Unison MedicalOS, a real-time operating system (RTOS) for medical applications and wearable devices.

With known challenges of cost, time to market, size and more, plus additional hurdles for certification across different countries and levels, Unison MedicalOS solves multiple pain points for medical OEM developers and programmers.

The RTOS enables OEM developers to design virtually any healthcare and medical device with low risk, minimum time to market and minimum lifecycle costs on a solid, focused platform, while providing selected, pre-qualified components with a broad set of features. These features can be quickly integrated to meet the needs of any development project, such as devices worn on the body for home healthcare, complete with medical certification support.

"Technological advances have paved the way for smart medical devices that not only shorten hospital stays, but also save lives," said Kim Rowe, CEO and founder of Rowebots. "Rowebots ensures developers have access to an RTOS that helps them easily design the medical devices of the future, adhering to security and certification protocols. Unison MedicalOS empowers developers to change healthcare for the better, from providing wearables with notifications for the elderly to take their medication to monitoring vital signs in case of an emergency."

To ensure security, a critical requirement in the healthcare industry, Unison MedicalOS leverages memory management protection to eliminate the dangers of dynamic loading, a clear liability when it comes to security. In addition to this foundational, architecture-based security, Unison MedicalOS also provides a suite of additional security-critical components, from secure SMTP to bootloader protocols, encryption/decryption and reliable wireless communication.

Supporting a choice of reliable and secure MCUs and MPUs, along with an RTOS environment tailored for very small systems, Unison MedicalOS features lean product development support, adaptable and modular architecture and full-layered security, among other characteristics. The RTOS also features support for the Microsoft Azure Cloud computing service. The ability to connect a set of services via this ready-made hub not only offers enhanced privacy and security, but also helps developers expand the capabilities of networked devices.

Unison MedicalOS is based on RoweBots' proven Unison RTOS solution, a real-time operating system that offers a complete component set for the development of IoT and M2M Communication Embedded Applications. The RTOS is designed to the well-known POSIX standard, and is optimized for size, modularity and adaptability to system-on-chip solutions, microcontroller units, microprocessor units, digital signal processing systems, field-programmable gate arrays and digital signal controllers. It is intended to help developers take products beyond the prototype level and add value with the opportunity for later expansion and enhancement of the product line.

Unison MedicalOS comes with a reference design kit to help developers create application designs for their projects. By connecting the components in the kit, developers can verify transfer of data and commands and use them as a platform to reliably begin development of innovative medical and healthcare applications.

RoweBots will demonstrate its Unison MedicalOS technology at Medica in DUsseldorf, Germany, November 13-16, 2017. To learn more, visit https://rowebots.com/.

About RoweBots:
RoweBots has delivered excellence in embedded systems products for over 30 years. The company's products are optimized specifically for those developing extremely small devices that require a broad set of embedded applications. Specifically, RoweBots' flagship products can assist with developing medical, wearable and IoT-enabled devices, drastically cutting down time to market and, in turn, costs associated with development.

PR Contact
Lauren Jaeger
Uproar PR for RoweBots
312.878.4575 x246
ljaeger@uproarpr.com

*LOGO for media: Send2Press.com/300dpi/17-1109s2p-rowebots-unison-300dpi.jpg

Today at Medica, the world's largest medical event, RoweBots, an embedded software company, announces the immediate availability of Unison MedicalOS, a real-time operating system (RTOS) for medical applications and wearable devices.

Related link: http://rowebots.com/

TSI’s Phantom XL3 Lateral Access System Redefines the Standard of Care in Spine Surgery

SUGAR LAND, Texas /ScoopCloud/ -- TeDan Surgical Innovations (TSI) today announced the launch of the Phantom XL3(TM) Lateral Access System for lumbar spine surgical retraction. A full product release will be held later this month at the North American Spine Society Meeting (NASS) in Orlando from October 25 to 27.

Unencumbered access to the anatomy while maintaining a small surgical incision remains a clinical challenge for the minimally invasive surgeon. The all-new Phantom XL3 transforms the approach by eliminating instrumentation fiddle factor through the integration of unparalleled surgical access design elements - all with the focus of elevating the surgeon's experience.

"There are a variety of lateral lumbar retractors available today, but finding the system that meets all of your needs as a surgeon can be difficult. The intuitive design of the Phantom XL3 provides reliable retraction with a sweeping blade motion unlike any retractor on the market," said James J. Lynch, MD, FAANS, CEO Spine Nevada.

As a full solution to lateral lumbar access, the Phantom XL3 comes equipped with an integrated 360-degree directional EMG neuromonitoring dilator kit as well as lighting and shim components to provide additional stability and visualization.

"With a rise in minimally invasive approaches (MIS) for spinal fusions, we believe that the versatility and ease of use offered with our Phantom XL3 Lateral Access System will redefine the standard of care for MIS approaches," said Terry Johnston, VP of Sales and Marketing of TSI.

For a full product showcase, visit the TSI booth #1723 and attend the NASS Simulation Lab. To learn more about TSI's Phantom XL3 Lateral Access System or to register for the lab, visit http://www.tedansurgical.com/ or call 877-726-0886.

About TeDan Surgical Innovations:

TeDan Surgical Innovations was founded in 2006 with the goal to innovate and address evolving techniques in surgical access. The company has developed a wide variety of retractors and disc prep instruments for posterior, lateral and anterior spine, as well as cardiothoracic, neurological and orthopedic procedures. TeDan Surgical Innovations is committed to providing high-quality, state-of-the-art medical devices that address customer and market needs.

For more information about TeDan Surgical Innovations, please visit http://www.tedansurgical.com/.

*PHOTO for media: Send2Press.com/300dpi/17-1023s2p-tedanx3-300dpi.jpg
*Photo Caption: TSI's Phantom XL3 Lateral Access System

*VIDEO (YouTube): https://youtu.be/ymYlapWQHkQ

TeDan Surgical Innovations (TSI) today announced the launch of the Phantom XL3(TM) Lateral Access System for lumbar spine surgical retraction. A full product release will be held later this month at the North American Spine Society Meeting (NASS) in Orlando from October 25 to 27.

Related link: http://www.tedansurgical.com/

Verify Smart Corporation Signs Letter of Intent to Acquire Equity Stake and Exclusive International Reseller Rights in Med-Con Technologies, LLC

FERNLEY, Nev. /ScoopCloud/ -- Verify Smart Corporation (OTC:VSMR / OTCMKTS:VSMR) a Global innovator in financial fraud prevention and digital distribution solutions announced today that it has signed a Letter of Intent to acquire an equity stake and exclusive international reseller rights in Med-Con Technologies, LLC for cash and stock.

Med-Con Technologies provides a patented solution (MedSked(TM)) for improved medication adherence. MedSked(TM) gives patients the ability to more effectively self-manage and keep track of their daily medication dosing. Med-Con's solutions are effectively assisting patients in over thirty two countries, and twenty four languages.

Med-Con has also developed MedCon Mobile Smart Label(TM) which is a mobile based patient adherence solution for the Pharmaceutical industry and is currently being tested by a major Pharmaceutical company with other pilots scheduled. The cloud based SaaS software manages the patient's medication dosing schedule via a mobile device while sending vital adherence data to the Pharmaceutical clinical trial teams for analysis via the MedCon Central(TM) data portal. Verify Smart and Med-Con believe this product is groundbreaking and a huge first to market play in the Pharmaceutical space.

Pharmaceutical Manufacturing Magazine said "Medication Adherence is arguably the largest problem in healthcare, it is estimated that medication non-adherence causes 30 - 50 percent of treatment failures and 125,000 deaths annually. The direct cost to healthcare is estimated as high as $289 billion annually. Pharmaceutical companies are motivated to increase adherence because higher compliance equates to better treatment effectiveness and overall better patient health...and of course, higher drug sales."

Tony Cinotti, President of Verify Smart said "Verify Smart will work closely with Med-Con Technologies to establish Verify Smart as the exclusive international reseller of MedSked and MedCon Mobile Smart Label for pharmaceutical companies, pharmacy chains and specialty pharmacy markets.

"Verify Smart will also, in parallel, build an additional adherence solution specifically for Retail Pharmacies. This will greatly increase Med-Con sales worldwide. Pharmacy customers taking prescription medications can now have the same benefits as Med-Con's corporate adherence solutions."

Anthony Londino, President of Med-Con Technologies commented "We are excited about working with Verify Smart to develop new products and broaden our reach into new markets and opportunities. Verify Smart's sales and marketing expertise, IT partners and extensive contacts in the retail pharmacy space will provide Med-Con with the additional resources to become the world leader in medication adherence and remote patient monitoring data."

About Verify Smart Corporation:
Verify Smart Corp is an international technology company that develops and markets innovative solutions for the global digital market. The company also licenses patented technology for the prevention of debit/credit card and electronic transaction fraud. The company is expanding into the growing digital and mobile sector and will market innovative solutions for pharmaceutical companies, consumer brands, educational institutions and the sports and entertainment industries.

Contact Info:
Verify Smart Corporation
Info@verifysmartcorp.com
775-575-5897
http://www.verifysmartcorp.com/

About Med-Con Technologies:
Med-Con Technologies LLC is a global provider of medication adherence solutions and services to the pharmaceutical market. Med-Con Technologies LLC has been helping some of the world's most prominent pharmaceutical companies to provide medication adherence support to their clinical trial and commercial patients. The company is expanding into the growing digital and mobile sector and has recently launched its MedSked Mobile Smart Label platform, a novel and innovative patient compliance solution.

Contact Info:
Med-Con Technologies LLC
http://www.medsked.com/
1-888-654-0856 ext. 125

REF: OTCMKTS:VSMR / OTC:VSMR / OTCBB:VSMR

Verify Smart Corporation (OTC:VSMR / OTCMKTS:VSMR) a Global innovator in financial fraud prevention and digital distribution solutions announced today that it has signed a Letter of Intent to acquire an equity stake and exclusive international reseller rights in Med-Con Technologies, LLC for cash and stock.

HeartIT and Siemens Healthineers Agree to Jointly Sell the Precession CMR Workflow Solution

DURHAM, N.C. /ScoopCloud/ -- Heart Imaging Technologies, LLC (HeartIT) and Siemens Healthineers have agreed to cooperatively sell the latest version of HeartIT's Precession cardiovascular magnetic resonance (CMR) workflow solution. Precession is the first browser-based CMR solution to combine medical image viewing, analysis, and reporting into one comprehensive, cloud-based platform.

Powered by HeartIT's patented zero-footprint WebPAX technologies, Precession supports accelerated image post-processing and multi-user collaboration via the cloud. A full suite of post-processing tools is included for quantifying cardiac ejection fraction, blood flow velocities, T1/T2 relaxation times, and 3D multi-planar reconstruction.

Precession provides single-mouse-click de-identification of patient data and real-time, cloud-based sharing of diagnostic-quality CMR and CCT scans, which enables physicians to quickly send images to referring physicians and colleagues. Detailed structured reports in both the English and German languages further support extensive research and data mining across users without compromising data security.

"Based on Medicare billing data, Precession software is used by six of the top 15 largest CMR centers in the United States," said Bilal Mir, director of sales at HeartIT. "These six sites also use MRI scanners from Siemens Healthineers, underscoring that the combination of our joint offerings can support the successful growth of CMR clinical volumes."

Precession has both FDA clearance and a CE mark, permitting distribution in the United States and European Union.

For more information, please contact:
Bilal Mir, Director of Sales
sales@heartit.com
+1 919-323-3001

About HeartIT:
Headquartered near North Carolina's Research Triangle Park, Heart Imaging Technologies was the first company to offer an FDA cleared zero footprint medical image workstation, which has become the precedent for other companies seeking FDA clearance. HeartIT provides web-based medical image management technology and services to health care systems, large hospitals and private clinics as well as drug and device companies sponsoring multi-center clinical trials. Worldwide, Heart Imaging Technologies solutions provide secure web browser access to over one billion medical images. For more information visit our website at http://heartit.com/.

About Siemens Healthineers:

Siemens Healthineers is the separately managed healthcare business of Siemens AG enabling healthcare providers worldwide to meet their current challenges and to excel in their respective environments. A leader in medical technology, Siemens Healthineers is constantly innovating its portfolio of products and services in its core areas of diagnostic and therapeutic imaging and in laboratory diagnostics and molecular medicine. Siemens Healthineers is also actively developing its digital health services and enterprise services.

To help customers succeed in today's dynamic healthcare marketplace, Siemens Healthineers is championing new business models that maximize opportunity and minimize risk for healthcare providers. In fiscal 2016, which ended on September 30, 2016, Siemens Healthineers generated revenue of €13.5 billion and profit of over €2.3 billion and has about 46,000 employees worldwide. Further information is available at https://www.siemens.com/healthineers/.

*LOGO for media: Send2Press.com/mediaboom/14-0930-heartit-300dpi.jpg

Heart Imaging Technologies, LLC (HeartIT) and Siemens Healthineers have agreed to cooperatively sell the latest version of HeartIT's Precession cardiovascular magnetic resonance (CMR) workflow solution. Precession is the first browser-based CMR solution to combine medical image viewing, analysis, and reporting into one comprehensive, cloud-based platform.

Paragon BioTeck Receives EN ISO 13485:2012 Certification

PORTLAND, Ore., March 29, 2016 (SEND2PRESS NEWSWIRE) -- Paragon BioTeck, Inc., a privately held pharmaceutical and medical device company, announced today that it has received EN ISO 13485:2012 certification, signifying the company's successful implementation of an effective quality management system.

The EN ISO 13485:2012 certification was awarded by the International Organization for Standardization, the world's largest developer and publisher of global quality and safety standards. This certification outlines specific requirements to establish and execute a structured quality management system for medical devices across all areas, from development to supply.

"Achieving this certification is an important milestone for Paragon BioTeck," said Lauren M-C Bluett, Director of Quality Assurance. "We have implemented a robust quality management system that conforms to ISO's global standards, demonstrating our commitment to excellence in product and operations through continuous improvement and quality by design."

Receipt of this certification paves the way for continued advancement of quality systems that meet world-class standards and maintain a central focus on patient safety and care.

About Paragon BioTeck, Inc.:

Paragon BioTeck, Inc., is a privately held pharmaceutical and medical device company specializing in the development and commercialization of ophthalmic pharmaceuticals, devices and therapies. Paragon BioTeck's portfolio of products is designed to protect and preserve eyesight and deliver comfort to the eyes.

These products include the Comfortear(R) Lacrisolve(TM) 180 Absorbable Punctum Plug, Comfortear(R) Punctum Plug, EqualEyes(R) Ocular Lubricant, the preservative-free ilast(R) range of products and their FDA-approved Phenylephrine Hydrochloride Ophthalmic Solution USP, available in 2.5% and 10%.

For more information about Paragon BioTeck and its products, please visit http://www.paragonbioteck.com/.

Join the conversation on Facebook ( https://www.facebook.com/ParagonBioTeck/ ) and Twitter: @ParagonBioTeck.

* LOGO for media: Send2Press.com/mediaboom/16-0329-paragonbio-300dpi.jpg

MEDIA CONTACT:
Michael Elofer
mike@pascalecommunications.com
(484) 620-6167

To view the original version on Send2Press Newswire, visit: https://www.send2press.com/newswire/paragon-bioteck-receives-en-iso-13485-2012-certification-2016-0329-02.shtml.

NEWS SOURCE Paragon BioTeck, Inc. :: This press release was issued on behalf of the news source (who is solely responsible for its accuracy) by and Copr. © 2016 Send2Press® Newswire, a service of Neotrope®.

MEDITE Cancer Diagnostics, Inc. will present at the SeeThruEquity Healthcare Investor Conference on January 11

ORLANDO, Fla., Jan. 7, 2016 (SEND2PRESS NEWSWIRE) -- MEDITE Cancer Diagnostics, Inc. (OTC:MDIT, the "Company"), specializing in the development, manufacturing, and marketing of molecular biomarkers and premium medical devices for detection, risk assessment and diagnosis of cancer and precancerous conditions announces today that CEO, Michaela Ott and CFO, Robert McCullough will present at the SeeThruEquity First Annual Microcap Healthcare Investor Conference on Monday, January 11, 2016, at the Fairmont San Francisco in San Francisco, Calif.

MEDITE, a USA based company now public through the merger with CytoCore Inc. has emerged as a German manufacturer focused on global sales of cancer diagnostic tools consisting of anatomic pathology, histology and cytology laboratory equipment and supplies. Recent agreements with U.S. distribution partners, Hospital Group Purchasing Organizations along with our Chinese partner UNIC Medical will allow the company to focus growth from historically based European sales to entry into the U.S., Latin America and a burgeoning and untapped Chinese market.

UNIC Medical selling MEDITE's equipment, which is already Chinese FDA registered, and cytology assays and stains is involved with the Chinese government in establishing first time country pathology standards for digitalized computer aided diagnosis of cancer in China, a country of 1.4 billion people with a lack of sufficient number of pathologists. As the company expands consumable cytology sales for cervical and breast cancer worldwide, current profitability should significantly expand as margins increase in the near future.

SeeThruEquity is an equity research and corporate access firm focused on companies with less than $1 billion in market capitalization. SeeThruEquity has initiated coverage on numerous NYSE, NASDAQ, TSX, and OTC companies in a variety of industries including technology, health care, consumer, energy and special situations.

About MEDITE Cancer Diagnostics, Inc.:

MEDITE Cancer Diagnostics, Inc. is a Delaware registered company consisting of wholly-owned MEDITE GmbH a Germany-based company with its subsidiaries. On April 3, 2014, MEDITE was acquired by former CytoCore, Inc. a biomolecular diagnostics company engaged in the design, development, and commercialization of cost-effective cancer screening systems and Biomarkers to assist in the early detection of cancer. By acquiring MEDITE the company changed from solely research operations to an operating company with a well-developed infrastructure, 71 employees in four countries, a distribution network to about 70 countries worldwide, a well-known and established brand name and a wide range of products for anatomic pathology, histology and cytology laboratories.

Forward Looking Statement:

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, regarding future operating performance, events, trends and plans. All statements other than statements of historical fact contained herein, including, without limitation, statements regarding our future financial position, business strategy, budgets, projected revenues and costs, and plans and objectives of management for future operations, are forward-looking statements. Forward-looking statements generally can be identified by the use of forward-looking terminology such as "may," "will," "expects," "intends," "plans," "projects," "estimates," "anticipates," or "believes" or the negative thereof or any variation thereon or similar terminology or expressions. We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are not guarantees and are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. Important factors that could cause our actual results to differ from our expectations, include but are not limited to, MEDITE's ability to maintain and grow its revenues, as well as those risk factors that apply to our operations as disclosed in Item 1A of our Report on Form 10-K for the year ended December 31, 2014 and other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on our forward-looking statements, as they speak only as of the date made. Such statements are not guarantees of future performance or events and we undertake no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances occurring after the date hereof.

For more information please visit: http://www.medite-group.com/.

Investor Contact:
Robert McCullough, Jr. CFO
407-996-9630

*LOGO for media: send2press.com/mediaboom/16-0107-medite-diag-300dpi.jpg

REF: OTCMKTS:MDIT

To view the original version on Send2Press Newswire, visit: https://www.send2press.com/newswire/medite-cancer-diagnostics-inc-will-present-at-the-seethruequity-healthcare-investor-conference-on-january-11-2016-0107-04.shtml.

NEWS SOURCE MEDITE Cancer Diagnostics, Inc. :: This press release was issued on behalf of the news source (who is solely responsible for its accuracy) by and Copr. © 2016 Send2Press® Newswire, a service of Neotrope®.

Enviromax Announces Complete New Line of Revolutionary External Prostate Massagers

ANCHORAGE, Alaska, Sept. 8, 2014 (SEND2PRESS NEWSWIRE) -- External prostate massage is a safe, easy, and fun way for men to learn how to stimulate their prostate, says men's health product manufacturer Enviromax.

"With our new product line, men simply sit on an external prostate massager to increase circulation to their prostate," says Adam McVay, Owner/Inventor, at Enviromax. "Increasing circulation has many health benefits according to research studies conducted by prestigious universities including Harvard Medical School. As an extra benefit, prostate massage can also make men feel better than they ever dreamed possible!"

The original Prostate Cradle was created in 2004 as the world's first patented external prostate massager. "The Cradle" was introduced as a device for men's health, but soon after it was introduced, Enviromax customers began writing in to say they were having the best sex of their lives while sitting on the Prostate Cradle.

The next model created by Enviromax was the Extra Soft Prostate Cradle. It is designed for men with sore or tender prostates. Enviromax's third model, the Prostate Jewel, was created due to customer demand for a more firm massager. "The Jewel" has the same anatomically correct shape as the Cradle, but without the cushioning holes for more stimulation to the prostate.

Enviromax is very excited about its newest and most affordable "entry-level" prostate massager called the Prostate Joy Pillow. The "Joy Pillow" is truly the softest prostate massager ever invented.

"Similar to the Cradle, the Joy Pillow can be purchased with a built-in vibrator feature that really helps to get men's prostate motor running!" adds McVay.

All Enviromax massagers are available in different sizes and colors.

"Men all over the world are discovering the joys of external prostate massage because it is so easy and accessible. No oils or towels are required. External prostate massagers offer both a complement and an alternative to traditional internal prostate massagers," explains McVay.

Enviromax products have been praised by Medical Doctors, urologists, and Licensed Massage Therapists. The Prostate Cradle has been featured in Muscle & Fitness magazine, as well as two popular books, "Healthy Prostate" by Ronald Bazar, and "The Ultimate Guide to Prostate Pleasure" by Charlie Glickman, PhD.

External prostate massagers are for adult men, ages 18 to 80+ years old, who want to maintain their physical health and improve their love-life. This includes men who are familiar with prostate massage, and men who may have been turned off in the past by traditional internal prostate massagers.

For more information, visit: http://www.ProstateCradle.com/ .

Video: http://youtu.be/K4gzP0OttAo .

*Image (SFW): Send2Press.com/mediaboom/14-0908-enviromax-300dpi.jpg .

To view the original version on Send2Press Newswire, visit: https://www.send2press.com/newswire/enviromax-announces-complete-new-line-revolutionary-external-prostate-massagers-2014-09-0908-002.shtml.

Leading Edge Veterinary Equipment Signs New Distributor, Midwest Veterinary Supply

DENVER, Colo., Dec. 16, 2013 (SEND2PRESS NEWSWIRE) -- Leading Edge Veterinary Equipment, an international supplier of new and exclusive veterinary medical equipment, announce their agreement with Midwest Veterinary Supply as the newest authorized distributor of Leading Edge products. Midwest Veterinary Supply is one of the country's premier animal health companies, recently celebrating its 50th Anniversary.

This partnership allows Leading Edge to further expand its market presence across North America. With a sales force of over 100 representatives, Midwest Veterinary Supply will now be adding a suite of more than 20 exclusive veterinary medical products to its equipment offerings, with more Leading Edge products coming to market in the near future.

"We are pleased to have Midwest Veterinary Supply as one of our exclusive distributors to help us deliver essential products to the veterinarian that 'Do more and Cost less'," says Scott Hopkins, Account Executive of Leading Edge Veterinary Equipment. "We're setting a new standard in medical equipment for the Veterinary professional, integrating innovation and world-class support that leads to improved patient care and a better experience for both the Veterinarian and the pet owner."

As a single source Veterinary medical equipment company, Leading Edge products are available only through a limited and select group of Distributors. Leading Edge product lines include fluid management, imaging, patient monitoring, microscopy, sterilization and others.

For more information on Leading Edge Veterinary Equipment visit: http://www.leadingedgevet.com/ .

Leading Edge provides Veterinary professionals high-performance, competitively priced, reliable Veterinary medical equipment, backed by world-class support and service. As a single source Veterinary medical equipment company, Leading Edge products are available only through a limited and select group of Distributors, who share in our philosophies and standards of excellence, commitment and service. Learn more at: http://www.leadingedgevet.com/ .

Original syndication source of this press release: http://i.send2press.com/eVE4D .

To view the original version on Send2Press Newswire, visit: https://www.send2press.com/newswire/Leading-Edge-Veterinary-Equipment-Signs-New-Distributor-Midwest-Veterinary-Supply_2013-12-1216-004.shtml.

NEWS SOURCE Leading Edge Veterinary Equipment :: This press release was issued on behalf of the news source (who is solely responsible for its accuracy) by and Copr. © 2013 Send2Press® Newswire, a service of Neotrope®.